KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients

KRAS is the most commonly mutated oncogene in human cancers. Targeted therapy and immunotherapy for this gene have made remarkable progress in recent years. However, comprehensive molecular landscape analysis of KRAS in rare tumors is lacking. Retrospective analysis was performed on clinical samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuhang, Li, Qin, Ma, Peiwen, Fang, Yuan, Yu, Yue, Jiang, Ning, Miao, Huilei, Tang, Qiyu, Yang, Yuqi, Xing, Shujun, Chen, Rongrong, Yi, Xin, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962378/
https://www.ncbi.nlm.nih.gov/pubmed/35359599
http://dx.doi.org/10.3389/fmolb.2022.831382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962378/
https://www.ncbi.nlm.nih.gov/pubmed/35359599
http://dx.doi.org/10.3389/fmolb.2022.831382

Ejemplares similares